Podcast: Lung Cancer Screening - Who Qualifies and How it Saves Lives

Ann Steagall, RN, BSN, SVP Patient Services and Health Care Delivery
lung cancer screening podcast

Lung cancer is often called a silent disease because it may not cause symptoms until it has spread. But when it's found early, the chance of cure can be very high. 

In this episode, family medicine physician and lung cancer screening leader Michael Gieske, MD, St. Elizabeth Healthcare, joins hosts Ann Steagall and Misty Shields, MD, to explain:

  • Who is eligible for lung cancer screening
  • Who may be at risk beyond current guidelines
  • What a low-dose CT scan is really like
  • Why follow-up on lung nodules matters

Listen as they discuss how screening is changing the story of lung cancer and bringing new hope to people at risk.
 

Make sure to subscribe to the podcast on Apple Podcasts or Spotify.

 

Featured Guests:

Michael Gieske, MD, Director of Lung Cancer Screening St. Elizabeth Healthcare

Michael Gieske, MD, is a member of LUNGevity’s Board of Directors and the Director of Lung Cancer Screening at St. Elizabeth Healthcare in Northern Kentucky, where he and his team have built one of the most successful lung cancer screening programs in the country. After completing his family medicine residency at St. Elizabeth, he practiced family medicine until 2022, when he left to dedicate his time to lung cancer screening awareness, policy, advocacy, and research. A fierce advocate for everyone at risk for or living with lung cancer, he also works on smoke-free policy and firefighter cancer screening.

If you catch lung cancer in stage one you can have a greater than ninety percent chance of cure.

Dr. Michael Gieske, Director of Lung Cancer Screening, St. Elizabeth Healthcare

 

Key Topics Discussed in This Episode:

  • Results from a decade of screening: Dr. Gieske shares how about two-thirds of the lung cancers his program has found were caught at stage I, when the chance of cure is highest
  • Who is eligible for screening: Dr. Gieske explains the current guidelines in plain terms, and why a conversation with your doctor is the best place to start
  • What a screening is really like: a quick, simple scan with one breath hold, often easier than people expect
  • Benefits, risks, and why guidelines matter: Ann asks about out-of-pocket “pop-up” screening clinics, and Dr. Gieske explains why follow-up through a trusted program matters
  • When a spot is found: what lung nodules are, what terms like Lung-RADS mean, and why keeping up with follow-up matters
  • Risk beyond current guidelines: Dr. Shields and Dr. Gieske discuss family history, radon, work exposures like firefighting, and how AI and blood-based tests may shape the future of screening
  • Talking to a loved one about screening: why “I love you, get screened” can be the most powerful motivator

 

Resources & Support: